Best Paper Award

Dear Colleagues,

We are pleased to announce the winners of the JPM 2019–2020 Best Paper Award. All of the papers that were published in JPM from 1 January 2019 to 31 December 2020 were considered for these awards. After a thorough evaluation of the originality and significance of the published papers, citations, and downloads, the three winning papers, which were nominated by the Editor-in-Chief, Prof. Dr. David Alan Rizzieri, were selected.

Rank 1 Award: (CHF 500 and the publication of one paper free of charge before 31 August 2022 following the normal peer-review procedure)
Molecular and Cellular Mechanisms Affected in ALS
By Laura Le Gall, Ekene Anakor, Owen Connolly, Udaya G. Vijayakumar, William J. Duddy and Stephanie Duguez
J. Pers. Med. 2020, 10(3), 101; doi: 10.3390/jpm10030101

Rank 2 Award: (CHF 300 and the publication of one paper free of charge before 31 August 2022 following the normal peer-review procedure)
Postulated Adjuvant Therapeutic Strategies for COVID-19
By Anderson O. Ferreira, Hudson C. Polonini and Eli C. F. Dijkers
J. Pers. Med. 2020, 10(3), 80; doi: 10.3390/jpm10030080

Rank 3 Award: (CHF 200 and the publication of one paper free of charge before 31 August 2022 following the normal peer-review procedure)
Evidences of CTLA-4 and PD-1 Blocking Agents-Induced Cardiotoxicity in Cellular and Preclinical Models
By Vincenzo Quagliariello, Margherita Passariello, Domenica Rea, Antonio Barbieri, Martina Iovine, Annamaria Bonelli, Antonietta Caronna, Gerardo Botti, Claudia De Lorenzo and Nicola Maurea
J. Pers. Med. 2020, 10(4), 179; doi: 10.3390/jpm10040179

On behalf of the assessment committee, I would like to congratulate the winners on their accomplishments. We would also like to take this opportunity to thank all of the nominated research groups of the abovementioned exceptional papers for their contributions to JPM and thank the award committee for voting and helping with this award.

Prof. Dr. David Alan Rizzieri, JPM
Editor-in-Chief

 
JPM Best Paper Award
 

Eligibility and Requirements

– All papers published in JPM will be eligible (Both regular and Special Issue submissions).
 
Past Winners
 
Year: 

Winner

18 pages, 7933 KB  
Review
Predicting the Onset of Diabetes with Machine Learning Methods
by Chun-Yang Chou, Ding-Yang Hsu and Chun-Hung Chou
J. Pers. Med. 2023, 13(3), 406; https://doi.org/10.3390/jpm13030406 - 24 Feb 2023
15 pages, 3274 KB  
Article
Challenging ChatGPT 3.5 in Senology—An Assessment of Concordance with Breast Cancer Tumor Board Decision Making
by Sebastian Griewing, Niklas Gremke, Uwe Wagner, Michael Lingenfelder, Sebastian Kuhn and Jelena Boekhoff
J. Pers. Med. 2023, 13(10), 1502; https://doi.org/10.3390/jpm13101502 - 16 Oct 2023

Award Committee

Dr. Kenneth Pritzker Chairperson

Winner

13 pages, 646 KB  
Review
Emergency Department Overcrowding: Understanding the Factors to Find Corresponding Solutions
by Gabriele Savioli, Iride Francesca Ceresa, Nicole Gri, Gaia Bavestrello Piccini, Yaroslava Longhitano, Christian Zanza, Andrea Piccioni, Ciro Esposito, Giovanni Ricevuti and Maria Antonietta Bressan
J. Pers. Med. 2022, 12(2), 279; https://doi.org/10.3390/jpm12020279 - 14 Feb 2022
14 pages, 1499 KB  
Article
Real-World Impact of a Pharmacogenomics-Enriched Comprehensive Medication Management Program
by Joseph P. Jarvis, Arul Prakasam Peter, Murray Keogh, Vince Baldasare, Gina M. Beanland, Zachary T. Wilkerson, Steven Kradel and Jeffrey A. Shaman
J. Pers. Med. 2022, 12(3), 421; https://doi.org/10.3390/jpm12030421 - 8 Mar 2022

Winner

Francine Durocher
1. Department of Molecular Medicine, Faculty of Medicine, Université Laval, Quebec City, QC G1T 1C2, Canada 2. Cancer Research Center, CHU de Québec-Université Laval, Quebec City, QC G1V 4G2, Canada
Zhiqiang Kevin Lu
College of Pharmacy, University of South Carolina, Columbia, SC 29208, USA

Winner

Molecular and Cellular Mechanisms Affected in ALS
Northern Ireland Center for Stratified/Personalised Medicine, Biomedical Sciences Research Institute, Ulster University, Derry-Londonderry BT47, UK
Postulated Adjuvant Therapeutic Strategies for COVID-19
Fagron. Lichtenauerlaan 182, 3062 Rotterdam, The Netherlands
Evidences of CTLA-4 and PD-1 Blocking Agents-Induced Cardiotoxicity in Cellular and Preclinical Models
CEINGE—Biotecnologie Avanzate s.c.a.r.l., 80131 Naples, Italy Department of Molecular Medicine and Medical Biotechnology, University of Naples “Federico II”, 80131 Napoli, Italy Division of Cardiology, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pasca

Award Committee

Prof. Dr. Richard E. Frye Chairperson
Autism Discovery and Treatment Foundation

Winner

S. Pamela K. Shiao
College of Nursing and Medical College of Georgia, Augusta University, Augusta, GA 30912, USA paper link: https://www.mdpi.com/2075-4426/8/1/10
Back to TopTop